No Prescription |
 |
 | ||
|
Piyeloseptyl Macrodantin |
|
| ||
No Prescription » Prescription Drugs 13 » Piyeloseptyl Macrodantin Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:This medication is used to treat or prevent certain urinary tract infections.This medication is an antibiotic that works by stopping the growth of bacteria. It will not work for viral infections (e.g. common cold flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.Nitrofurantoin should not be used in children less than one month of age due to the risk of a certain blood problem (hemolytic anemia).How to use Nitrofurantoin OralTake this medication by mouth with food or milk as directed by your doctor. This medication is usually taken four times daily to treat an infection or once daily at bedtime to prevent infections. Swallow the medication whole. Avoid using magnesium trisilicate-containing antacids while taking this medication. Magnesium trisilicate-containing antacids bind with nitrofurantoin preventing its full absorption.Dosage and duration is based on your medical condition and response to therapy. For children the dosage is also based on body weight.Antibiotics work best when the amount of medicine in your body is kept at a constant level. Therefore take this medication at evenly spaced intervals.When taking this medication to prevent infection take it exactly as directed by your doctor. Do not skip doses or stop taking it without your doctor's approval. Inform your doctor if you notice signs of a new urinary tract infection (e.g. pain while you are urinating).If you are taking this medication to treat an infection continue to take this medication until the full-prescribed amount is finished even if symptoms disappear after a few days. Stopping the medication too early may allow bacteria to continue to grow which may result in a relapse of the infection. Inform your doctor if your condition persists or worsens.Nitrofurantoin Oral is used to treat the following:Bladder Infection caused by Enterobacter Infection of the Urinary Tract caused by Enterococcus Urinary Tract Infection due to E. Coli Bacteria Urinary Tract Infection caused by Klebsiella Bacteria Urinary Tract Infection caused by Staphylococcus Aureus Staphylococcus Saprophyticus Infection of Urinary TractNitrofurantoin Oral may also be used to treat:Urinary Tract Infection Prevention Buy Piyeloseptyl Macrodantin and other Prescription Drugs 13 products online at Medstore. 4997
About Piyeloseptyl Macrodantin: Product Type: Prescription Drugs 13 Piyeloseptyl ( Macrodantin Generic Nitrofurantoin ) Piyeloseptyl (Macrodantin Generic Nitrofurantoin) Macrodantin Generic Nitrofurantoin 50 mg 30 caps Macrodantin Generic Nitrofurantoin Piyeloseptyl
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
